NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
EPCPRIMING MEDIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPCPRIMING MEDIA
ST13
US500000098235398Class
5
Filing
98235398
Registration
7576619
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
11/26/2024
Trademark type
Word
Nice classes
5
Filing date
10/23/2023
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Cheongju-si, KR
Examiner
KHOURI, SANI
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
YOUTH BIO GLOBAL Co., Ltd.
Representatives
Josephine A. Brosas LEWIS BRISBOIS BISGAARD & SMITH LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Animal-extracted and cultured pharmaceutical preparations for the treatment of stem cells; animal-extracted and cultured pharmaceutical preparations for the treatment of cells; pharmaceutical preparations for activating cellular function using adult stem cells; pharmaceutical preparations for the treatment of cells using adult stem cells; pharmaceutical preparations of cellular function for the treatment of ischemic vascular diseasesstem cellsbacterial infectioncancer; drugs for medical purposesnamely pharmaceutical preparations for the treatment of ischemic vascular diseasesstem cellsbacterial infectioncancer; Human-extracted and cultured pharmaceutical preparations for the treatment of cells; Human-extracted and cultured pharmaceutical preparations for the treatment of stem cells; Stem cells for medical use; pharmaceutical preparations for activating cellular function using stem cells; cytostatic for pharmaceutical purposes using stem cells; pharmaceutical preparations for the treatment of stem cells; therapeutic drugs and agentsnamely pharmaceutical preparations for the treatment of ischemic vascular diseasesstem cellsbacterial infectioncancer.
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2024
GNRT
NON-FINAL ACTION E-MAILED
06/12/2024
CNRT
NON-FINAL ACTION WRITTEN
06/12/2024
DOCK
ASSIGNED TO EXAMINER
06/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2023
NWAP
NEW APPLICATION ENTERED
10/26/2023
Continuous trademark protection
Get notified about every new filing that threatens EPCPRIMING MEDIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.